Skip to main content
HR 349 117th Congress House

Coronavirus Vaccine and Therapeutic Development Act of 2021

Official title: To direct the Secretary of Health and Human Services to award contracts, grants, and cooperative agreements to expand and enhance capacity for manufacturing co… Show full official titleShow less

Official title: To direct the Secretary of Health and Human Services to award contracts, grants, and cooperative agreements to expand and enhance capacity for manufacturing covered products to prevent and control the spread of SARS-CoV-2 and COVID-19.

Introduced: February 2, 2021 See on congress.gov
Health Cardiovascular and respiratory healthCongressional oversightEmergency medical services and trauma careHealth promotion and preventive care
More subjectsShow fewer subjects
Health technology, devices, suppliesImmunology and vaccinationInfectious and parasitic diseasesManufacturingPublic contracts and procurementResearch and development
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 5, 2021
Sponsor introductory remarks on measure. (CR H393)
Feb 2, 2021
Referred to the Subcommittee on Health.
Jan 19, 2021
Referred to the House Committee on Energy and Commerce.
Jan 19, 2021
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 5, 2021

Sponsor introductory remarks on measure. (CR H393)

 Plain-English summary Congressional Research Service

Coronavirus Vaccine and Therapeutic Development Act of 2021

This bill directs the Department of Health and Human Services (HHS) to increase the supply of vaccines and medical products that prevent or control COVID-19 (i.e., coronavirus disease 2019). To increase supplies, HHS must, as appropriate, award grants and enter other transactions to expand relevant research, procurement, and production activities.

HHS must report to Congress on these actions. The report must assess and detail plans to enhance the supply chain and manufacturing capacity for the vaccines and products. It must also include plans to support domestic and international vaccination programs.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Cosponsors 10
All 10 Democratic 9
Demings, Val
· Feb 24, 2021
 D
Frankel, Lois
Florida · Feb 2, 2021
 D
Schrier, Kim
Washington · Feb 2, 2021
 D
Sewell, Terri A.
Alabama · Feb 2, 2021
 D
Strickland, Marilyn
Washington · Feb 2, 2021
 D
Blunt Rochester, Lisa
Delaware · Jan 28, 2021
 D
Brownley, Julia
California · Jan 28, 2021
 D
Trahan, Lori
Massachusetts · Jan 28, 2021
 D
Williams, Nikema
Georgia · Jan 28, 2021
 D
Jeffries, Hakeem S.
New York · Jan 19, 2021
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 349: Coronavirus Vaccine and Therapeutic Development Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-349/
MLA
"H.R. 349: Coronavirus Vaccine and Therapeutic Development Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-349/.
Bluebook (legal)
H.R. 349, 117th Cong. (2026), https://openamerica.io/bill/117-HR-349/.
Markdown link
[H.R. 349: Coronavirus Vaccine and Therapeutic Development Act of 2021](https://openamerica.io/bill/117-HR-349/)
Report a problem